Chakravarthy Krishnan V, Chaturvedi Rahul, Agari Takashi, Iwamuro Hirokazu, Reddy Rajiv, Matsui Ayano
Division of Pain Medicine, Department of Anesthesiology, University of California San Diego Health Center, 9400 Campus Point Dr, La Jolla, San Diego, CA USA.
VA San Diego Health Care, 3350 La Jolla Village Dr, San Diego, CA USA.
Bioelectron Med. 2020 Sep 28;6:18. doi: 10.1186/s42234-020-00055-3. eCollection 2020.
In this study we analyze new clinical data in the use of spinal cord stimulation (SCS) for the treatment of pain and motor symptoms in patients with Parkinson's Disease (PD), as both a singular bioelectric therapy and as a salvage therapy after deep brain stimulation (DBS).
Fifteen patients were recruited and had percutaneous electrodes implanted at the level of the thoracic or cervical spine. Participants were set to one of three stimulation modes: continuous tonic stimulation, continuous Burst stimulation (40 Hz, 500 Hz, 1000 μs), or cycle mode (on time of 10-15 s, off time of 15-30 s) with Burst (40 Hz, 500 Hz, 1000 μs). Patients completed the Visual Analogue Scale (VAS), Unified Parkinson's Disease Rating Scale, Self-Rating Depression Scale, Hamilton Depression Rating Scale, Profile of Mood State, 10-meter walking test, and the Timed Up and Go (TUG).
All patients experienced significant improvement in VAS scores with a mean reduction of 59% across all patients. Patients who chose the cycling burst stimulation parameter had an average 67% reduction in VAS scores, as compared to the continuous burst parameter group, which had an average 48% reduction in VAS scores. Seventy-three percent of patients experienced improvement in the 10-meter walk, with an average improvement of 12%. Sixty-four percent of patients experienced clinically relevant improvements in the TUG, with an average improvement of 21%.
This study points to the potential utility of SCS to address both pain and certain aspects of motor symptoms in PD patients who have and have not received DBS therapy.
在本研究中,我们分析了脊髓刺激(SCS)用于治疗帕金森病(PD)患者疼痛和运动症状的新临床数据,SCS既作为一种单独的生物电疗法,也作为深部脑刺激(DBS)后的挽救疗法。
招募了15名患者,在胸段或颈段脊柱水平植入经皮电极。参与者被设置为三种刺激模式之一:持续强直刺激、持续爆发刺激(40Hz、500Hz、1000μs)或带有爆发(40Hz、500Hz、1000μs)的循环模式(开启时间10 - 15秒,关闭时间15 - 30秒)。患者完成视觉模拟量表(VAS)、统一帕金森病评定量表、自评抑郁量表、汉密尔顿抑郁评定量表、情绪状态剖面图、10米步行测试以及定时起立行走测试(TUG)。
所有患者的VAS评分均有显著改善,所有患者的平均降低幅度为59%。选择循环爆发刺激参数的患者VAS评分平均降低67%,而持续爆发参数组的VAS评分平均降低48%。73%的患者10米步行有改善,平均改善12%。64%的患者在TUG测试中有临床相关改善,平均改善21%。
本研究指出SCS对于已接受和未接受DBS治疗的PD患者在缓解疼痛和改善某些运动症状方面具有潜在效用。